(A) Scheme of the adult Drosophila melanogaster gastrointestinal tract with cartoon depicting the midgut epithelial monolayer composed of intestinal stem cells (ISC), enteroblasts (EB), enterocytes …
Data from Figure 1.
Panel G,H experimental data.
(A) Expression analysis of Ecdysone-receptor splice variants with specific primer sets performed on cDNA transcribed from mRNA isolations of whole midgut dissections of adult MF. (B–D) Antibody …
Data from Figure 1—figure supplement 1.
Panel H experimental data.
(A–C) Determination of 20HE titers in ovaries and hemolymph of wild-type (A,B) and ovoD1 (B,C) adult VF and MF 48 hr after mating. (A,C) show fold-change increases over VF titer (dotted line at y = 1…
Data from Figure 2.
Panel A,B,C,J,O,P,Q experimental data.
(A) Drosophila food tubes of w1118 control egg layings to determine concentrations of RH5849. Please note that there is no crawling L3-larvae and puparium formation in both RH5849 concentrations. …
Data from Figure 2—figure supplement 1.
Panel H,O experimental data.
(A) Cartoon depicting EcR signaling cascade activating early ecdysteroid target genes. (B) Expression analysis of Ecdysone- and JH-signaling target genes including protein isoforms on cDNA …
Data from Figure 3.
Panel C,L,M experimental data.
(A–E’’) Representative images of MARCM clones of the indicated allele five days after clone induction (ACI) counterstained with Dlg-1 and Pros immunohistochemistry. Control clones lead to proper EC …
Data from Figure 3—figure supplement 1.
Panel D,E,F,G experimental data.
(A) Cartoon depicting kluReDDM-tracing. klu-Gal4 is active in EC-committed EB only and EC progeny is labelled with nuclear H2B::RFP (Reiff et al., 2019). (B–D’’) Representative images of MF controls …
Data from Figure 3—figure supplement 2.
Panel A,J,K,L experimental data.
(A–D) Representative images of adult PMG after seven days of esgReDDM tracing of control MF (A,B) and >Eip75 B-RNAi MF (C,D) fed with DMSO as control (A,C, 2.5 µl/ml food) and Pioglitazone (B,D; …
Data from Figure 4.
Panel E,F experimental data.
(A–B) Images of adult PMG of control VF (A) and forced expression of > Kr h1 (B) traced for seven days with esgReDDM. (C–H) Images of adult PMG with forced expression of > Kr h1 with > Eip75 B-RNAi …
Data from Figure 5.
Panel I,J experimental data.
(A) Cartoon depicting cell fate changes upon N-LOF combined with esgReDDM coloring (Ohlstein and Spradling, 2006; Ohlstein and Spradling, 2007). (B) > N RNAi driven by esgReDDM leads to different …
Data from Figure 6.
Panel F,I,J experimental data.
(A) Quantification of ISC progeny encompassing ISC-like, EC and EE classified after tumor size (classes I to IV) in R5 PMG of esgReDDM > N RNAi (n = 10,10,10). Error bars are Standard Error of the …
Data from Figure 6—figure supplement 1.
Panel A experimental data.
(A–E’’) Pharmacological and genetic manipulation of Ecdysone signaling. Adult PMG of MF with N-LOF (>N RNAi or > NDN) treated with MeOH as control (A–A’’) or RH5849 (B–B’’) to activate Ecdysone …
Data from Figure 7.
Panel F,G experimental data.
(A–E’’) Representative images of MARCM clones for the Notch receptor (N55e11) in MF PMG four days after clone induction (ACI) counterstained with Dlg-1 and Pros antibodies. Control Notch clones …
Data from Figure 7—figure supplement 1.
Panel C,G experimental data.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Genetic reagent (Drosophila melanogaster) | esgReDDM | Antonello et al., 2015a DOI: 10.15252/embj.201591517 | Figures 1–7; Figure 1—figure supplement 1; Figure 3—figure supplement 1 | |
Genetic reagent (D. melanogaster) | esgReDDM > Eip75B-A | Rabinovich et al., 2016 DOI: 10.1016/j.cell.2015.11.047 | Figure 3; Figure 3—figure supplement 1 | |
Genetic reagent (D. melanogaster) | esgReDDM > Eip75B-B | Rabinovich et al., 2016 DOI: 10.1016/j.cell.2015.11.047 | Figure 3; Figure 3—figure supplement 1 | |
Genetic reagent (D. melanogaster) | esgReDDM > Eip75B-C | Rabinovich et al., 2016 DOI: 10.1016/j.cell.2015.11.047 | Figure 3; Figure 3—figure supplement 1 | |
Genetic reagent (D. melanogaster) | Srebp > CD8::GFP | Reiff et al., 2015 DOI: 10.7554/eLife.06930 | Figure 2—figure supplement 1 | |
Genetic reagent (D. melanogaster) | Mex > ts | Phillips and Thomas, 2006 DOI: 10.1242/jcs.02839 | Figure 2—figure supplement 1 | |
Genetic reagent (D. melanogaster) | MARCM (FRT2A) | Lee and Luo, 1999 DOI: 10.1016/S0896-6273 (00)80701–1 | Figure 3—figure supplement 1 | |
Genetic reagent (D. melanogaster) | Eip75A81-MARCM (FRT2A) | Rabinovich et al., 2016 DOI: 10.1016/j.cell.2015.11.047 | Figure 3—figure supplement 1 | |
Genetic reagent (D. melanogaster) | kluReDDM | Reiff et al., 2019 DOI: 10.15252/embj.2018101346 | Figure 3—figure supplement 2 | |
Genetic reagent (D. melanogaster) | N55e11-MARCM (FRT19A) | Guo and Ohlstein, 2015 DOI: 10.1126/science.aab0988 | Figure 7—figure supplement 1 | |
Chemical compund, drug | RH5849 | DrEhrenstorfer | DRE-C16813000 | 340 µM final concentration |
Chemical compund, drug | Pioglitazone | Sigma-Aldrich | Sigma-Aldrich 112529-15-4 | 14 µM final concentration |